← Back to Clinical Trials
Recruiting NCT06604936

NCT06604936 Investigation of Core Endurance in Fibromyalgia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06604936
Status Recruiting
Phase
Sponsor Firat University
Condition Fibromyalgia
Study Type OBSERVATIONAL
Enrollment 20 participants
Start Date 2024-09-17
Primary Completion 2024-10-14

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type OBSERVATIONAL
Interventions
Fibromyalgia groupHealthy group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 20 participants in total. It began in 2024-09-17 with a primary completion date of 2024-10-14.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to compare core endurance and balance in patients with Fibromyalgia Syndrome (FMS) with healthy subjects and to evaluate the relationship between core endurance and balance.The study will include 44 FMS patients and 44 age- and sex-matched healthy controls. Demographic data of the participants will be recorded. Then, core endurance will be assessed with McGill core endurance tests, balance will be evaluated with HUR BTG4 Balance Master System and Berg Balance Scale (BBS), and function will be assessed with Fibromyalgia Impact Questionnaire (FIQ).

Eligibility Criteria

Inclusion Criteria: * Patients who were aged between 18-65 years, * Patients who got diagnosed with Fibromyalgia Syndrome Exclusion Criteria: * Patients who had regular exercise habits, malignancy, pregnancy, incorporation * Patients who had changes of medical treatment in last 3 months * Patients who had dysfunction that can prevent physical activity

Frequently Asked Questions

Who can join the NCT06604936 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Fibromyalgia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06604936 currently recruiting?

Yes, NCT06604936 is actively recruiting participants. Visit ClinicalTrials.gov or contact Firat University to inquire about joining.

Where is the NCT06604936 trial being conducted?

This trial is being conducted at Elâzığ, Turkey (Türkiye).

Who is sponsoring the NCT06604936 clinical trial?

NCT06604936 is sponsored by Firat University. The trial plans to enroll 20 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology